NexGard for Dogs: The Science Behind How It Kills Fleas and Ticks

If you've ever watched your dog scratch relentlessly or found a tick embedded behind their ear, you understand why reliable parasite prevention matters. NexGard (afoxolaner) has become one of the most-prescribed oral flea and tick preventives in the United States since its FDA approval in 2013. But unlike topical treatments that sit on the skin, NexGard works from the inside out — a mechanism rooted in decades of parasitology and neuropharmacology research.

This article breaks down the actual science of how NexGard works in your dog's body, why the isoxazoline drug class represents a breakthrough in parasite control, and what peer-reviewed research tells us about safety, efficacy, and limitations.

The Pharmacology of Afoxolaner: NexGard's Active Ingredient

The molecular mechanism is precise: afoxolaner acts as a non-competitive antagonist at two critical receptor sites in the flea or tick's nervous system:

• GABA-gated chloride channels — Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in invertebrates. When GABA binds to its receptor, chloride ions flow into the neuron, calming electrical activity. Afoxolaner blocks this channel, preventing chloride influx.
• Glutamate-gated chloride channels (GluCl) — These are unique to invertebrates and do not exist in mammals. Glutamate normally opens these channels to inhibit nerve firing. Afoxolaner blocks them as well.

With both inhibitory pathways blocked, the parasite's neurons fire uncontrollably. The result is hyperexcitation, tremors, paralysis, and death — typically within hours of the parasite taking its first blood meal from a treated dog.

Why Doesn't Afoxolaner Harm Dogs?

The selectivity comes down to receptor structural differences between mammals and arthropods. Mammalian GABA receptors have a different subunit composition and three-dimensional binding pocket shape than insect or acarine (tick) GABA receptors. Afoxolaner has approximately 100-fold greater affinity for invertebrate GABA receptors than for mammalian ones, according to pharmacokinetic studies published in Veterinary Parasitology. Additionally, mammals lack glutamate-gated chloride channels entirely, so the second mechanism of action has no mammalian target at all.

That said, the mammalian GABA receptor is not completely immune — which is why adverse neurological events, though rare, are possible. We address this in the safety section below.

How NexGard Is Absorbed, Distributed, and Eliminated in Dogs

Understanding the pharmacokinetics — how the drug moves through your dog's body — explains both its effectiveness and its monthly dosing schedule.

NexGard (Afoxolaner) Pharmacokinetic Profile in Dogs

Parameter	Value
Time to peak blood concentration (Tmax)	2–4 hours post-dose
Bioavailability (with food)	~87% (enhanced by feeding)
Half-life (t½)	~15 days (range 12–18 days)
Volume of distribution	High — distributes widely into tissues including skin
Primary elimination route	Biliary/fecal excretion (liver metabolism)
Flea kill onset	Within 8 hours of administration
Tick kill onset	24–48 hours (species-dependent)
Duration of efficacy	30 days (full month)

The 15-day half-life is key: it means the drug concentration gradually declines over the month but remains above the minimum effective concentration (MEC) needed to kill parasites for the full 30-day period. By day 30, blood levels are low enough that a new dose is needed to maintain protection.

The Role of Food in Absorption

Afoxolaner is a lipophilic (fat-soluble) molecule. Boehringer Ingelheim, the manufacturer, recommends administering NexGard with or without food, but pharmacokinetic data shows that concurrent feeding — particularly food containing fat — increases absorption by approximately 15–20%. The beef-flavored chewable formulation itself contains fats that aid absorption, which is part of its design.

Evolutionary Context: Why Parasite Pressure Shaped Canine History

Fleas (Ctenocephalides felis, the cat flea, which infests dogs as well) can lay up to 50 eggs per day and complete their lifecycle in as few as 12 days under warm, humid conditions. A single untreated female flea on your dog can seed your home with hundreds of offspring within two weeks. This reproductive advantage is why speed of kill matters: NexGard's ability to kill fleas before they lay eggs (within 8 hours) breaks the environmental lifecycle — something slower-acting products cannot consistently achieve.

Efficacy Data: What Clinical Research Shows

NexGard's efficacy has been evaluated in multiple controlled studies submitted for FDA approval and published in peer-reviewed journals.

Flea Efficacy

In a pivotal study published in Veterinary Parasitology (2014), dogs treated with afoxolaner at the label dose (2.5 mg/kg) showed:

• ≥95.3% flea reduction at 8 hours post-treatment
• ≥99.0% flea reduction at 24 hours and maintained through Day 28
• Prevention of flea egg production from Day 2 onward

Tick Efficacy

Against the four major tick species affecting U.S. dogs:

NexGard Tick Kill Efficacy by Species (Peer-Reviewed Data)

Tick Species	Common Name	Efficacy at 48 Hours	Duration of Protection
Rhipicephalus sanguineus	Brown dog tick	≥97%	28 days
Dermacentor variabilis	American dog tick	≥93%	28 days
Amblyomma americanum	Lone Star tick	≥90%	28 days
Ixodes scapularis	Black-legged (deer) tick	≥87%	28 days

The Ixodes scapularis data is particularly significant because this species transmits Borrelia burgdorferi, the bacterium that causes Lyme disease. By killing these ticks within 48 hours — often before the 36–48 hour attachment window required for Borrelia transmission — NexGard reduces but does not completely eliminate Lyme disease risk. The AKC notes that no single product provides 100% tick-borne disease protection, and owners in high-risk areas should discuss additional strategies with their veterinarian.

Safety Profile: What the FDA Data and Post-Market Surveillance Reveal

NexGard carries FDA approval, which required submission of target animal safety studies, field efficacy trials, and human food safety assessments (for dogs that might enter the food chain, though this is irrelevant for pet dogs).

Common Side Effects

In pre-approval field studies involving 615 dogs, the most frequently reported adverse events were:

• Vomiting — reported in approximately 2.0% of treated dogs
• Diarrhea — reported in approximately 1.1%
• Lethargy — reported in approximately 0.8%
• Decreased appetite — reported in approximately 0.5%

These rates are comparable to placebo groups, suggesting some events may be coincidental rather than drug-related. Most gastrointestinal events are mild and self-resolving within 24 hours.

Neurological Adverse Events: The Isoxazoline Class Warning

In 2018, the FDA issued a warning about the isoxazoline drug class (including afoxolaner, fluralaner, sarolaner, and lotilaner) and potential neurological adverse events:

• Muscle tremors
• Ataxia (uncoordinated movement)
• Seizures

These events are rare but documented. The mechanism relates to afoxolaner's action on GABA receptors — while mammalian GABA receptors have low affinity for the drug, individual variation in blood-brain barrier permeability or pre-existing neurological conditions may increase susceptibility.

Breed Considerations

Unlike ivermectin, where the MDR1 gene mutation in herding breeds (Collies, Australian Shepherds) creates a well-documented toxicity risk, no breed-specific contraindication exists for afoxolaner. The MDR1 mutation affects P-glycoprotein transport at the blood-brain barrier, which impacts macrocyclic lactones (ivermectin, moxidectin) but has not been shown to affect isoxazoline transport. That said, individual sensitivity can occur in any breed, and monitoring your dog for the first 24 hours after the first dose is always prudent.

Myths vs. Facts: Common Misconceptions About NexGard

Myth	Fact
"NexGard is a pesticide that poisons your dog's blood."	Afoxolaner is a parasiticide with ~100x selectivity for invertebrate over mammalian GABA receptors. The therapeutic dose (2.5 mg/kg) provides a wide safety margin — target animal safety studies showed no adverse effects at 5x the label dose for 6 consecutive months.
"Fleas have to bite my dog for NexGard to work, so it doesn't really protect them."	Fleas and ticks must bite to ingest the drug — this is true. However, kill speed is fast enough (8 hours for fleas) that most parasites die before they can transmit disease or lay eggs. The bite itself is brief and typically causes no reaction.
"NexGard causes cancer in dogs."	No peer-reviewed study or FDA report has linked afoxolaner to canine neoplasia. The FDA's post-market surveillance database tracks adverse events, and carcinogenicity testing was part of the original approval package. This claim appears to originate from misinterpreted anecdotal online reports.
"Natural flea prevention is just as effective."	Essential oil sprays, diatomaceous earth, and garlic supplements have not demonstrated consistent, reproducible flea/tick kill rates in controlled studies. Garlic, in particular, is toxic to dogs at effective doses and can cause hemolytic anemia.
"I can split a NexGard tablet for a smaller dog."	NexGard chewables are not scored and the active ingredient may not be evenly distributed throughout the tablet. Splitting risks under-dosing (ineffective) or over-dosing (increased side effect risk). Buy the correct weight-class product.

Practical Implications for Dog Owners

When Parasite Behavior Signals a Bigger Problem

Sometimes what looks like a flea problem is actually a symptom of something else. Watch for these scenarios:

• Persistent scratching despite confirmed parasite control: May indicate atopic dermatitis (environmental allergies), food allergy, or yeast/bacterial skin infection. A veterinary dermatology workup including skin cytology and allergy testing may be needed.
• Visible fleas 48+ hours after NexGard administration: Could indicate a heavy environmental infestation (new fleas emerging from pupae faster than the drug kills them) or, rarely, a product quality issue. Verify the product was purchased from a licensed source — counterfeit parasiticides are documented in online marketplaces.
• Neurological signs (tremors, disorientation, seizures) after dosing: Contact your veterinarian immediately. While rare, these events require professional evaluation. Report the adverse event to the FDA's Safety Reporting Portal.
• Tick-borne illness symptoms despite prevention: Fever, lameness, swollen lymph nodes, or lethargy may indicate Lyme disease, Ehrlichiosis, or Anaplasmosis. No parasiticide is 100% effective, and your vet may recommend a 4DX SNAP test to screen for tick-borne pathogens.

How NexGard Compares to Other Parasiticide Classes

Oral vs. Topical Flea and Tick Prevention: Mechanism Comparison

Feature	NexGard (Oral Isoxazoline)	Fipronil/Topical	Fluralaner (Bravecto)
Route of administration	Oral chewable	Topical spot-on	Oral chewable or topical
Duration	30 days	30 days	8–12 weeks
Water/bath resistance	Fully resistant	Reduced for 48 hrs post-application	Fully resistant (oral)
Mechanism	Systemic GABA/GluCl antagonist	Contact neurotoxin on skin/hair	Same class (isoxazoline), longer half-life
Heartworm coverage	None (separate product needed)	None (varies by product combo)	None
Typical 6-month cost	$85–$120	$60–$100	$50–$80 (2 doses cover 6 mo)

A critical note: NexGard does not protect against heartworms, intestinal parasites, or mites (though afoxolaner has shown efficacy against Demodex and Sarcoptes mites in studies). Many owners pair NexGard with a separate heartworm preventive like Heartgard Plus (ivermectin/pyrantel) or use a combination product like NexGard PLUS, which adds heartworm and intestinal parasite coverage.

Frequently Asked Questions About NexGard for Dogs

Is NexGard safe for all dog breeds?

Yes. NexGard has no breed-specific contraindications. Unlike ivermectin-based products, the MDR1 gene mutation found in Collies, Australian Shepherds, and related breeds does not affect afoxolaner safety. However, individual sensitivity can occur in any breed, and dogs with seizure histories should be evaluated by a veterinarian before use.

Can I give NexGard to my puppy?

NexGard is approved for puppies 8 weeks of age and older weighing at least 4 pounds (1.8 kg). Puppies younger than 8 weeks or under 4 pounds should not receive NexGard. Consult your veterinarian for age-appropriate parasite control options for very young puppies.

What happens if my dog eats more than one NexGard tablet?

Safety studies tested afoxolaner at 5x the label dose for 6 months without significant adverse effects, providing a wide margin of safety. However, accidental overdose may increase the likelihood of vomiting or lethargy. If your dog consumes multiple tablets, contact your veterinarian or the ASPCA Animal Poison Control Center at (888) 426-4435 (24/7, consultation fee applies) for guidance.

Does NexGard protect against mosquitoes or heartworms?

No. NexGard targets fleas and ticks only. It does not repel mosquitoes or prevent heartworm infection (Dirofilaria immitis). You will need a separate heartworm preventive — typically a monthly oral or topical macrocyclic lactone — in addition to NexGard.

Can NexGard be used with other medications?

Afoxolaner has been evaluated alongside common veterinary medications including vaccines, anthelmintics, antibiotics, and steroids without documented interactions. However, because afoxolaner acts on GABA receptors, concurrent use with other GABA-active drugs (phenobarbital, diazepam, gabapentin) warrants veterinary oversight. Always inform your veterinarian of all medications and supplements your dog receives.

Why does my dog still have fleas after starting NexGard?

The most common reason is environmental reinfestation. Flea pupae in carpets, bedding, and yard soil can continue hatching for 2–3 months after you begin treatment. Each newly hatched flea must bite your dog, ingest the afoxolaner, and die — which happens within 8 hours, but you may see fleas during that window. Consistent monthly dosing combined with environmental management (vacuuming, washing bedding, treating the yard) will resolve the infestation over 2–3 months.